Diagnostic Accuracy of Parkinson’s disease: Where Do We Stand?
Objective: To provide an up-to-date assessment of diagnostic accuracy parameters at early and late stages of the diagnosis in clinical practice and MDS Diagnostic Criteria…A systematic review of Movement Disorders in COVID-19
Objective: We conducted a systematic review to describe the frequency, clinical profile and outcomes of patients with SARS-CoV-2 associated movement disorders. Background: SARS-CoV-2 is associated…Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia
Objective: To explore the goal attainment scale (GAS) by interviewing the three most disturbing problems and changes after Botulinum toxin A injection in cervical dystonia…Administration of the mGlu2 positive allosteric modulator BINA as monotherapy improves parkinsonism in the MPTP-lesioned marmoset
Objective: To assess the effect of selective metabotropic glutamate type 2 (mGlu2) receptor activation on parkinsonism as monotherapy in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset compared to…DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson’s Progression Marker Initiative (PPMI) cohort
Objective: Compare baseline whole blood DNA methylation in unmedicated idiopathic Parkinson's Disease (iPD) and healthy control (HC) participants from PPMI Background: Epigenetic mechanisms like DNA…Effect of Subthalamic Nucleus Stimulation (STN-DBS) on psychosocial function using the scale “SCOPA-PS” in patients with Parkinson’s Disease at the National Institute of Neurology and Neurosurgery in Mexico during 2007 to 2020.
Objective: To determine the psychosocial function of patients with Parkinson's disease, with history of subthalamic nucleus stimulation, using the SCOPA-PS questionnaire. Background: Parkinson's disease (PD)…Anti-Ma2 Antibody Paraneoplastic Cerebellar Degeneration Associated with Renal Cell Carcinoma: A Case Report.
Objective: To highlight a unique case of Anti-Ma2 antibody paraneoplastic cerebellar degeneration (PCD) associated with renal cell carcinoma (RCC). Background: Paraneoplastic neurologic syndromes are a…Reversible secondary parkinsonism attributed to metformin-induced lactic acidosis
Objective: We describe the case of a 59-year-old man who was evaluated for abnormal imaging and subacute parkinsonism. Background: Secondary parkinsonism can be caused by…Characterization of Perioperative Seizures in Patients Undergoing Deep Brain Stimulation for Movement Disorders: A Single-Center Study
Objective: To characterize perioperative seizures in movement disorder patients undergoing deep brain stimulation (DBS) and their outcome. Background: Although seizure is a rare complication of…CLINICAL CORRELATION OF VISUAL LEUKOARAIOSIS SCALES AND VOLUMETRIC ANALYSIS IN PATIENTS WITH ISCHEMIC CEREBRAL VASCULAR EVENT AND PARKINSON’S DISEASE.
Objective: Search for the clinical correlation of the most used leukoaraiosis scales in Parkinson's disease and ischemic stroke. Background: In recent decades, there has been…
- « Previous Page
- 1
- …
- 638
- 639
- 640
- 641
- 642
- …
- 1734
- Next Page »